Clinical Trial Update: Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates pembrolizumab in combination with endocrine therapy and palbociclib for postmenopausal patients with newly diagnosed metastatic est…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-24